Related Experiment Videos
T-cell malignancy following B-cell lymphoma in remission
K Shimizu1, M Hirano, F Maruyama
1Department of Medicine, Fujita Gakuen Health University, School of Medicine, Japan.
American Journal of Clinical Pathology
|September 1, 1989
Summary
A patient developed T-cell malignancy after B-cell lymphoma remission. This could indicate biclonal lymphoma, secondary lymphoma, or a single stem cell transforming from B- to T-cell types.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- A 64-year-old male patient had a history of recurrent B-cell lymphoma.
- The patient achieved one and a half years of remission before developing a new malignancy.
Observation:
- A new T-cell malignancy was diagnosed in the patient.
- Immunophenotypic and DNA analyses were performed on both lymphoid malignancies.
Findings:
- Both the initial B-cell lymphoma and the subsequent T-cell malignancy were confirmed to be clonal.
- The cell lineage of both lymphoid malignancies was identified.
- The sequential development suggests possibilities including biclonal lymphoma, treatment-related secondary lymphoma, or intraclonal conversion from a lymphoid stem cell.
Implications:
- This case presents a rare instance of sequential B-cell and T-cell malignancies in a single patient.
- Understanding the underlying mechanism (biclonality, secondary transformation, or stem cell conversion) is crucial for patient management.
- Further research into lymphoid stem cell plasticity may offer new therapeutic targets for complex hematologic malignancies.